Your browser doesn't support javascript.
Checkpoint inhibitor therapy for skin cancer may be safe in patients with asymptomatic COVID-19.
Trojaniello, C; Vitale, M G; Ascierto, P A.
  • Trojaniello C; Department Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
  • Vitale MG; Department Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
  • Ascierto PA; Department Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy. Electronic address: paolo.ascierto@gmail.com.
Ann Oncol ; 32(5): 674-676, 2021 05.
Article in English | MEDLINE | ID: covidwho-1085591

Full text: Available Collection: International databases Database: MEDLINE Main subject: Skin Neoplasms / Coronavirus Infections / COVID-19 Limits: Humans Language: English Journal: Ann Oncol Journal subject: Neoplasms Year: 2021 Document Type: Article Affiliation country: J.annonc.2021.02.008

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Skin Neoplasms / Coronavirus Infections / COVID-19 Limits: Humans Language: English Journal: Ann Oncol Journal subject: Neoplasms Year: 2021 Document Type: Article Affiliation country: J.annonc.2021.02.008